SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-14-008786
Filing Date
2014-12-08
Accepted
2014-12-08 16:44:05
Documents
1
Period of Report
2014-12-04

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f4120414schaber_soligenix.html 4  
1 OWNERSHIP DOCUMENT f4120414schaber_soligenix.xml 4 4024
  Complete submission text file 0001213900-14-008786.txt   5783
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Issuer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address
SCHABER CHRISTOPHER J (Reporting) CIK: 0001068029 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-16929 | Film No.: 141272960